Cargando…
Hepatitis C elimination: challenges with under-diagnosis and under-treatment
Hepatitis C infection has affected 189 million people globally and more than 4 million in the US. Owing to remarkable advances in the therapeutic sphere, essentially all infected patients can be expected to achieve cure. This provides an unprecedented opportunity to eliminate the risk of complicatio...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338244/ https://www.ncbi.nlm.nih.gov/pubmed/30687501 http://dx.doi.org/10.12688/f1000research.15892.1 |
_version_ | 1783388426631905280 |
---|---|
author | Terrault, Norah A |
author_facet | Terrault, Norah A |
author_sort | Terrault, Norah A |
collection | PubMed |
description | Hepatitis C infection has affected 189 million people globally and more than 4 million in the US. Owing to remarkable advances in the therapeutic sphere, essentially all infected patients can be expected to achieve cure. This provides an unprecedented opportunity to eliminate the risk of complications from hepatitis C and to reduce the spread of the virus to others. To achieve this, a streamlined cascade of care from diagnosis to treatment may be enacted. Although great strides have been made, under-diagnosis and under-treatment remain major hurdles. |
format | Online Article Text |
id | pubmed-6338244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-63382442019-01-24 Hepatitis C elimination: challenges with under-diagnosis and under-treatment Terrault, Norah A F1000Res Review Hepatitis C infection has affected 189 million people globally and more than 4 million in the US. Owing to remarkable advances in the therapeutic sphere, essentially all infected patients can be expected to achieve cure. This provides an unprecedented opportunity to eliminate the risk of complications from hepatitis C and to reduce the spread of the virus to others. To achieve this, a streamlined cascade of care from diagnosis to treatment may be enacted. Although great strides have been made, under-diagnosis and under-treatment remain major hurdles. F1000 Research Limited 2019-01-14 /pmc/articles/PMC6338244/ /pubmed/30687501 http://dx.doi.org/10.12688/f1000research.15892.1 Text en Copyright: © 2019 Terrault NA http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Terrault, Norah A Hepatitis C elimination: challenges with under-diagnosis and under-treatment |
title | Hepatitis C elimination: challenges with under-diagnosis and under-treatment |
title_full | Hepatitis C elimination: challenges with under-diagnosis and under-treatment |
title_fullStr | Hepatitis C elimination: challenges with under-diagnosis and under-treatment |
title_full_unstemmed | Hepatitis C elimination: challenges with under-diagnosis and under-treatment |
title_short | Hepatitis C elimination: challenges with under-diagnosis and under-treatment |
title_sort | hepatitis c elimination: challenges with under-diagnosis and under-treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338244/ https://www.ncbi.nlm.nih.gov/pubmed/30687501 http://dx.doi.org/10.12688/f1000research.15892.1 |
work_keys_str_mv | AT terraultnoraha hepatitisceliminationchallengeswithunderdiagnosisandundertreatment |